Literature DB >> 10401711

Mineralocorticoid status and endocrine dysfunction in severe hemochromatosis.

L M Hempenius1, P S Van Dam, J J Marx, H P Koppeschaar.   

Abstract

Selective iron deposition in the zona glomerulosa of the adrenal cortex is observed in hemochromatosis. Hypoaldosteronism should be excluded before starting venesection, to avoid long-term volume depletion. We evaluated the aldosterone status in patients with hemochromatosis. As other endocrine organs can be affected by the disease as well, we simultaneously evaluated anterior pituitary, gonadal, thyroid and pancreatic beta-cell activity. Nine patients with hereditary or acquired hemochromatosis and highly increased plasma ferritin levels were investigated. In patients, liver cirrhosis had been confirmed histologically. Five patients complained of sexual dysfunction, and one had impaired glucose tolerance. Plasma aldosterone (PA) and renin activity (PRA) were measured after a period of normal (100 mmol/day) and low (10 mmol/day) sodium intake. A combined anterior pituitary function test and a glucagon stimulation test were undertaken to evaluate other endocrine functions. Both PA and PRA levels were decreased in one patient with liver cirrhosis, who also presented attenuated cortisol, prolactin and gonadotrophin secretion. No patients had signs of primary hypoaldosteronism with hyperreninemia. Hypogonadotropic hypogonadism was observed in 3 males and 1 female. Pituitary ACTH reserve was impaired in 2, GH and prolactin response in 1, and thyroid function in none of the patients. Glucagon-stimulated plasma C-peptide was impaired in one patient. In conclusion, primary aldosterone deficiency was not observed in patients with severe iron overload. Hyporeninemic hypoaldosteronism was found in one patient who also presented other endocrinopathies. Hypogonadotropic hypogonadism is the most frequent endocrine abnormality in hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401711     DOI: 10.1007/BF03343575

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Hemochromatosis and hemosiderosis. Study of 211 autopsied cases.

Authors:  R A MACDONALD; G K MALLORY
Journal:  Arch Intern Med       Date:  1960-05

2.  Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda.

Authors:  M Santos; H C Clevers; J J Marx
Journal:  N Engl J Med       Date:  1997-05-01       Impact factor: 91.245

3.  Pituitary function in idiopathic haemochromatosis: hormonal study in 36 male patients.

Authors:  B Charbonnel; M Chupin; A Le Grand; J Guillon
Journal:  Acta Endocrinol (Copenh)       Date:  1981-10

4.  Adrenocortical function in idiopathic haemochromatosis.

Authors:  B Charbonnel; M Chupin; B Lucas; F Chupin; J Guillon
Journal:  Acta Endocrinol (Copenh)       Date:  1980-09

5.  Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study.

Authors:  C Bergeron; K Kovacs
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

6.  Endocrine abnormalities in idiopathic haemochromatosis.

Authors:  C Walton; W F Kelly; I Laing; D E Bu'lock
Journal:  Q J Med       Date:  1983

7.  A direct radioimmunoassay for the determination of adrenocorticotropic hormone (ACTH) and a clinical evaluation.

Authors:  C J Arts; H P Koppeschaar; W Veeman; J H Thijssen
Journal:  Ann Clin Biochem       Date:  1985-05       Impact factor: 2.057

8.  The endocrine manifestations of hemochromatosis.

Authors:  L W McNeil; L C McKee; D Lorber; D Rabin
Journal:  Am J Med Sci       Date:  1983 May-Jun       Impact factor: 2.378

9.  Mineralocorticoid and glucocorticoid status in idiopathic haemochromatosis.

Authors:  C H Walsh; A L Murphy; S Cunningham; T J McKenna
Journal:  Clin Endocrinol (Oxf)       Date:  1994-10       Impact factor: 3.478

10.  Haemochromatosis and aldosterone deficiency presenting with Yersinia pseudotuberculosis septicaemia.

Authors:  S P Conway; N Dudley; P Sheridan; H Ross
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

View more
  4 in total

Review 1.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

2.  Evaluation of the glucocorticoid, mineralocorticoid, and adrenal androgen secretion dynamics in a large cohort of patients aged 6-18 years with transfusion-dependent β-thalassemia major, with an emphasis on the impact of cardiac iron load.

Authors:  Ahmet Uçar; Nergiz Öner; Gülcihan Özek; Mehmet Güli Çetinçakmak; Mahmut Abuhandan; Ali Yıldırım; Cemil Kaya; Sena Ünverdi; Hamdi Cihan Emeksiz; Yasin Yılmaz; Aylin Yetim
Journal:  Endocrine       Date:  2016-02-02       Impact factor: 3.633

Review 3.  Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress.

Authors:  Paraskevi Roussou; Nikolaos J Tsagarakis; Dimitrios Kountouras; Sarantis Livadas; Evanthia Diamanti-Kandarakis
Journal:  Anemia       Date:  2013-12-16

Review 4.  Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.

Authors:  Gavin Y Oudit; Maria G Trivieri; Neelam Khaper; Peter P Liu; Peter H Backx
Journal:  J Mol Med (Berl)       Date:  2006-04-08       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.